| Literature DB >> 34917646 |
Qian Xu1, Guangyong Zhang2, Linchuan Li2, Fengting Xiang3, Linhui Qian4, Xiufang Xu5, Zhibo Yan6.
Abstract
Background: During lower abdominal marginal hernia repair, the peritoneal flap is routinely freed to facilitate mesh placement and closed to conclude the procedure. This procedure is generally called trans-abdominal partial extra-peritoneal (TAPE). However, the necessity of closing the free peritoneal flap is still controversial. This study aimed to investigate the safety and feasibility of leaving the free peritoneal flap in-situ.Entities:
Keywords: free peritoneal flap; incisional hernia; laparoscopic hernia repair; lower abdominal; marginal hernia; suprapubic hernia
Year: 2021 PMID: 34917646 PMCID: PMC8669332 DOI: 10.3389/fsurg.2021.748515
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1To classify the lower abdominal marginal hernia, four zones were defined according to the European Hernia Society (EHS) classification.
Inclusion and exclusion criteria.
|
|
| Adult patients with lower abdominal marginal hernia classified as M5, L3 or partial M4 and L2 which need to free peritoneal during the operation according to the European Hernia Society (EHS) classification. |
| Tolerant to surgery and anesthesia. |
| Unilateral hernia. |
|
|
| Patients with contraindications of laparoscopic surgery, such as: |
| Poor cardiopulmonary function or any vital organ dysfunction. |
| Blood coagulation disorder. |
| Severe hemorrhagic disease. |
| Intolerant to surgery and anesthesia. |
| Patients underwent emergency surgery. |
Mesh brands in two groups.
|
|
|
|
|
|---|---|---|---|
| Bard ® Composix E/X Mesh ( | 0/0.0 | 1/2.3 | 1 |
| Covidien ® Parietex composite ( | 4/16.0 | 10/23.3 | 0.548 |
| Bard ® Sepramesh ( | 21/84.0 | 32/74.4 | 0.545 |
Data are expressed as numbers and percentages.
Fixation of mesh in patients who underwent laparoscopic hernia repair.
|
|
|
|---|---|
| Auto-suture tacks ( | 59/86.8 |
| Medical adhesive ( | 3/4.4 |
| Absorbable suture ( | 6/8.8 |
Data are expressed as numbers and percentages.
Comparison of demographics, comorbidities and hernia characteristics of patients in two groups.
|
|
|
|
|
|---|---|---|---|
|
|
| ||
| Age (years) | 59.3 ± 12.2 | 62.7 ± 11.0 | 0.241 |
|
| 0.944 | ||
| Male | 6/24.0 | 10/23.3 | |
| Female | 19/76.0 | 33/76.7 | |
| BMI (kg/m2) | 26.6 ± 3.2 | 25.9 ± 3.9 | 0.44 |
|
| 0.902 | ||
| ≤1 months | 2/8.0 | 2/4.7 | |
| ≤6 months | 6/24.0 | 12/27.9 | |
| ≤1 years | 8/32.0 | 16/37.2 | |
| ≤5 years | 6/24.0 | 7/16.3 | |
| >5 years | 3/12.0 | 6/13.9 | |
|
| 0.128 | ||
| Left flank | 6/24.0 | 3/7.0 | |
| Right flank | 10/40.0 | 19/44.2 | |
| Median | 9/36.0 | 21/48.8 | |
|
| |||
| Incision infection | 1/4.0 | 1/2.3 | 1 |
| Chronic constipation | 0/0.0 | 3/7.0 | 0.292 |
| Chronic cough | 2/8.0 | 3/7.0 | 0.876 |
|
| 0.137 | ||
| Open | 22/88.0 | 42/97.7 | |
| Laparoscopic | 3/12.0 | 1/2.3 | |
|
| |||
| CHD | 3/12.0 | 7/16.3 | 0.735 |
| Diabetes | 3/12.0 | 9/20.9 | 0.513 |
| Hypertension | 7/28.0 | 20/46.5 | 0.133 |
| Smoking ( | 3/12.0 | 6/14.0 | 1 |
| Recurrent hernia ( | 6/24.0 | 4/9.3 | 0.066 |
|
| 0.57 | ||
| < | 17/68.0 | 32/74.4 | |
| ≥ | 8/32.0 | 11/25.6 | |
| Follow-up time (months) | 58.8 ± 21.6 | 61.4 ± 27.7 | 0.683 |
Data are expressed as mean ± SD or as numbers and percentages.
BMI body mass index, CHD coronary heart disease, ASA American society of anesthesiologists.
Previous surgery in patients who underwent laparoscopic hernia repair.
|
|
|
|
|
|---|---|---|---|
| Bowel related ( | 11/44.0 | 20/46.5 | 0.841 |
| Gynecological ( | 5/20.0 | 12/27.9 | 0.468 |
| Urological ( | 1/4.0 | 4/9.3 | 0.645 |
| Incisional hernia repair ( | 6/24.0 | 4/9.3 | 0.154 |
| Others ( | 2/8.0 | 3/7.0 | 1 |
Data are expressed as numbers and percentages.
Comparison of perioperative parameters in two groups.
|
|
|
|
|
|---|---|---|---|
|
|
| ||
| Hernia size (cm2) | 118.5 ± 104.6 | 94.4 ± 82.4 | 0.297 |
| Defect size (cm2) | 90.2 ± 79.2 | 88.7 ± 77.2 | 0.943 |
| Mesh size (cm2) | 301.4 ± 94.0 | 331.1 ± 148.4 | 0.372 |
| Diameter of hernia ring (cm) | 6.2 ± 3.1 | 6.7 ± 3.4 | 0.536 |
| Operative time (min) | 114.0 ± 16.8 | 98.8 ± 19.4 | 0.002 |
| Intra-operative bleeding volume (ml) | 21.2 ± 10.1 | 28.7 ± 18.4 | 0.065 |
| Intra-operative visceral injury ( | 0/0.0 | 0/0.0 | |
| Hospital stay (days) | 12.9 ± 4.5 | 13.1 ± 4.1 | 0.809 |
| Seroma ( | 5/20.0 | 0/0.0 | 0.005 |
| Urinary retention ( | 0/0.0 | 0/0.0 | |
|
| 0.981 | ||
| Bowel related | 1/4.0 | 2/4.7 | |
| Hernia repair | 1/4.0 | 1/2.3 | |
| Others | 1/4.0 | 2/4.7 | |
| Hybrid surgery ( | 6/24.0 | 8/18.6 | 0.596 |
Data are expressed as mean ± SD or as numbers and percentages.
Fisher's exact test was used and a p-value of < 0.05 is considered significant.
Student's t test was used and a p-value of < 0.05 is considered significant.
Comparison of postoperative VAS score, pain days, recurrence and other complications.
|
|
|
|
|
|---|---|---|---|
|
|
| ||
|
| 0.63 | ||
| 0 | 14/56.0 | 29/67.5 | |
| ≤3 | 10/40.0 | 13/30.2 | |
| ≤6 | 1/4.0 | 1/2.3 | |
| ≤10 | 0/0.0 | 0/0.0 | |
|
| 0.916 | ||
| ≤7 days | 5/13.6 | 8/13.2 | |
| ≤1 months | 14/59.1 | 22/52.6 | |
| ≤3 months | 4/18.2 | 10/26.3 | |
| >3 months | 2/9.1 | 3/7.9 | |
| Dysuria ( | 0/0.0 | 0/0.0 | |
| Intestinal obstruction ( | 0/0.0 | 0/0.0 | |
| SSI ( | 0/0.0 | 1/2.3 | 1 |
| Mesh infection ( | 0/0.0 | 1/2.3 | 1 |
| Recurrence ( | 0/0.0 | 2/4.7 | 0.528 |
Data are expressed as numbers and percentages.
SSI, Surgical site infection.